These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29394350)

  • 1. Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk.
    Bergmark BA; Scirica BM; Steg PG; Fanola CL; Gurmu Y; Mosenzon O; Cahn A; Raz I; Bhatt DL;
    Eur Heart J; 2018 Jun; 39(24):2255-2262. PubMed ID: 29394350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.
    Böhm M; Schumacher H; Teo KK; Lonn E; Mahfoud F; Mann JFE; Mancia G; Redon J; Schmieder R; Weber M; Sliwa K; Williams B; Yusuf S
    Eur Heart J; 2018 Sep; 39(33):3105-3114. PubMed ID: 29873709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk.
    Böhm M; Schumacher H; Teo KK; Lonn EM; Mahfoud F; Mann JFE; Mancia G; Redon J; Schmieder RE; Marx N; Sliwa K; Weber MA; Williams B; Yusuf S
    Eur Heart J; 2019 Jul; 40(25):2032-2043. PubMed ID: 30919899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
    Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S
    Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline: A Pooled Cohort Analysis.
    Pandey A; Patel KV; Vongpatanasin W; Ayers C; Berry JD; Mentz RJ; Blaha MJ; McEvoy JW; Muntner P; Vaduganathan M; Correa A; Butler J; Shimbo D; Nambi V; deFilippi C; Seliger SL; Ballantyne CM; Selvin E; de Lemos JA; Joshi PH
    Circulation; 2019 Dec; 140(25):2076-2088. PubMed ID: 31707797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering on Cardiovascular Outcomes and All-Cause Mortality in Type 2 Diabetes.
    Ilkun OL; Greene T; Cheung AK; Whelton PK; Wei G; Boucher RE; Ambrosius W; Chertow GM; Beddhu S
    Diabetes Care; 2020 Aug; 43(8):1878-1884. PubMed ID: 32366577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized Trial of the Effects of Insulin and Metformin on Myocardial Injury and Stress in Diabetes Mellitus: A Post Hoc Exploratory Analysis.
    Srivastava PK; Pradhan AD; Cook NR; Ridker PM; Everett BM
    J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29275373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino-terminal-pro-B-type natriuretic peptide levels and low diastolic blood pressure: potential relevance to the diastolic J-curve.
    Campbell DJ; McGrady M; Prior DL; Coller JM; Boffa U; Shiel L; Liew D; Wolfe R; Stewart S; Reid CM; Krum H
    J Hypertens; 2014 Nov; 32(11):2158-65; discussion 2165. PubMed ID: 25275245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.
    Böhm M; Schumacher H; Teo KK; Lonn EM; Mahfoud F; Mann JFE; Mancia G; Redon J; Schmieder RE; Sliwa K; Weber MA; Williams B; Yusuf S
    Lancet; 2017 Jun; 389(10085):2226-2237. PubMed ID: 28390695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systolic and diastolic blood pressure time in target range and cardiovascular outcomes in patients with hypertension and pre-frailty or frailty status.
    Zhu J; Yang K; Liu W
    J Clin Hypertens (Greenwich); 2024 May; 26(5):514-524. PubMed ID: 38552135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contributions of Systolic and Diastolic Blood Pressures to Cardiovascular Outcomes in the ALLHAT Study.
    Itoga NK; Tawfik DS; Montez-Rath ME; Chang TI
    J Am Coll Cardiol; 2021 Oct; 78(17):1671-1678. PubMed ID: 34674811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systolic blood pressure levels among adults with hypertension and incident cardiovascular events: the atherosclerosis risk in communities study.
    Rodriguez CJ; Swett K; Agarwal SK; Folsom AR; Fox ER; Loehr LR; Ni H; Rosamond WD; Chang PP
    JAMA Intern Med; 2014 Aug; 174(8):1252-61. PubMed ID: 24935209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes: An Exploratory Analysis From the RELAX-AHF Trial.
    Pang PS; Teerlink JR; Voors AA; Ponikowski P; Greenberg BH; Filippatos G; Felker GM; Davison BA; Cotter G; Kriger J; Prescott MF; Hua TA; Severin T; Metra M
    JACC Heart Fail; 2016 Jul; 4(7):591-599. PubMed ID: 27039129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure level associated with lowest cardiovascular event in hypertensive diabetic patients.
    Lee CJ; Hwang J; Lee YH; Oh J; Lee SH; Kang SM; Choi D; Kim HC; Park S
    J Hypertens; 2018 Dec; 36(12):2434-2443. PubMed ID: 30015754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive Blood Pressure Lowering in Patients With and Patients Without Type 2 Diabetes: A Pooled Analysis From Two Randomized Trials.
    Brouwer TF; Vehmeijer JT; Kalkman DN; Berger WR; van den Born BH; Peters RJ; Knops RE
    Diabetes Care; 2018 Jun; 41(6):1142-1148. PubMed ID: 29212825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of NT-proBNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugs.
    Ruff CT; Morrow DA; Jarolim P; Ren F; Contant CF; Kaur A; Curtis SP; Laine L; Cannon CP; Brune K
    J Rheumatol; 2011 Jun; 38(6):1071-8. PubMed ID: 21459935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Optimal Diastolic Blood Pressure Range Among Adults With Treated Systolic Blood Pressure Less Than 130 mm Hg.
    Li J; Somers VK; Gao X; Chen Z; Ju J; Lin Q; Mohamed EA; Karim S; Xu H; Zhang L
    JAMA Netw Open; 2021 Feb; 4(2):e2037554. PubMed ID: 33595663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NT-proBNP by Itself Predicts Death and Cardiovascular Events in High-Risk Patients With Type 2 Diabetes Mellitus.
    Malachias MVB; Jhund PS; Claggett BL; Wijkman MO; Bentley-Lewis R; Chaturvedi N; Desai AS; Haffner SM; Parving HH; Prescott MF; Solomon SD; De Zeeuw D; McMurray JJV; Pfeffer MA
    J Am Heart Assoc; 2020 Oct; 9(19):e017462. PubMed ID: 32964800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis.
    Bangalore S; Messerli FH; Franklin SS; Mancia G; Champion A; Pepine CJ
    Eur Heart J; 2009 Jun; 30(11):1395-401. PubMed ID: 19351690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Outcomes After Intensive Blood Pressure Lowering: Findings From the SPRINT Randomized Clinical Trial.
    Berry JD; Nambi V; Ambrosius WT; Chen H; Killeen AA; Taylor A; Toto RD; Soliman EZ; McEvoy JW; Pandey A; Joshi PH; Blankenberg S; Kitzman DW; Ballantyne CM; de Lemos JA
    JAMA Cardiol; 2021 Dec; 6(12):1397-1405. PubMed ID: 34468696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.